Bridging pharmacology and pathophysiology via systems modeling.
作者信息
D'Argenio David Z, Mager Donald E
机构信息
Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, USA.
出版信息
J Clin Pharmacol. 2010 Sep;50(9 Suppl):56S-57S. doi: 10.1177/0091270010377505.
Abstract
摘要
相似文献
1
Bridging pharmacology and pathophysiology via systems modeling.
J Clin Pharmacol. 2010 Sep;50(9 Suppl):56S-57S. doi: 10.1177/0091270010377505.
2
Systems biology, connectivity and the future of medicine.
Syst Biol (Stevenage). 2005 Dec;152(4):174-8. doi: 10.1049/ip-syb:20050034.
3
Positron emission tomography for use in microdosing studies.
Curr Opin Drug Discov Devel. 2008 Jan;11(1):104-10.
4
On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems.
IEEE Trans Biomed Eng. 2004 Mar;51(3):408-14. doi: 10.1109/TBME.2003.820996.
5
Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
Drug Discov Today. 2011 Dec;16(23-24):1031-6. doi: 10.1016/j.drudis.2011.10.001. Epub 2011 Oct 13.
6
Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
CPT Pharmacometrics Syst Pharmacol. 2020 Feb;9(2):75-76. doi: 10.1002/psp4.12493. Epub 2020 Jan 26.
7
Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan?
Clin Pharmacol Ther. 2013 May;93(5):379-81. doi: 10.1038/clpt.2013.40.
8
Quantitative systems pharmacology for shifting the drug discovery and development paradigm.
Biopharm Drug Dispos. 2013 Dec;34(9):475-6. doi: 10.1002/bdd.1870.
9
Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
J Pharmacol Exp Ther. 2009 Dec;331(3):767-74. doi: 10.1124/jpet.109.157172. Epub 2009 Sep 24.
10
Feedback control indirect response models.
J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):343-58. doi: 10.1007/s10928-016-9479-8. Epub 2016 Jul 9.
本文引用的文献
1
Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.
Clin Pharmacokinet. 2008;47(7):417-48. doi: 10.2165/00003088-200847070-00001.
2
Disease system analysis: basic disease progression models in degenerative disease.
Pharm Res. 2005 Jul;22(7):1038-49. doi: 10.1007/s11095-005-5641-5. Epub 2005 Jul 22.
Zotero 插件